Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|November 23, 2022
Central nervous system involvement by mantle cell lymphomaNicole McLaughlin, Yucai Wang, Thomas Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
Blood|May 22, 2012
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experienceAnita D'Souza, Martha Lacy, Morie Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2022
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic ExperienceJustin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2021
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell LymphomaMadiha Iqbal, Yennifer Gil Castano, Jonas Paludo, et al.
American Journal of Hematology|January 2, 2023
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experienceKaran L Chohan, Jonas Paludo, Nishanth Vallumsetla, et al.
Blood Cancer Journal|December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
American Journal of Hematology|February 24, 2017
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapyAllison Rosenthal, Amylou C Dueck, Stephen Ansell, et al.
British Journal of Haematology|August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomesJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
Pageof 3